Поисковый запрос: (<.>S=ОТВЕТ НА ЛЕЧЕНИЕ<.>) |
Общее количество найденных документов : 70
Показаны документы с 1 по 20
|
|
1.
| A colorectal cancer classification system that associates cellular phenotype and responses to therapy // Nature Med., 2013. Vol. 19, N 5.-С.619-625
|
2.
| A colorectal cancer classification system that associates cellular phenotype and responses to therapy // Nature Med., 2013. Vol. 19, N 5.-С.619-625
|
3.
| A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366
|
4.
| A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366
|
5.
| Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: Characteristics and significance // Ann. Oncol., 2000. Vol. 11, N 12.-С.1571-1577
|
6.
| Robinson M.R.G. Carcinoma of the prostate. Objective criteria of response // Amer. J. Clin. Oncol., 1988. Vol. 11, Suppl. N2.-С.48-52
|
7.
| CCNU (lomustine), idarubicin and dexamethasone (CIDEX): An effective oral regimen for the treatment of refractory or repalsed myeloma // Brit. J. Haematol., 2000. Vol. 109, N 3.-С.571-575
|
8.
| CCNU (lomustine), idarubicin and dexamethasone (CIDEX): An effective oral regimen for the treatment of refractory or repalsed myeloma // Brit. J. Haematol., 2000. Vol. 109, N 3.-С.571-575
|
9.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
10.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
11.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
12.
| Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant // J. Med. Virol., 2014. Vol. 86, N 5.-С.851-856
|
13.
| Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372
|
14.
| Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372
|
15.
| Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540
|
16.
| Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540
|
17.
| Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540
|
18.
| Franchini L. Familial concordance of SSRIs response as a tool for differentiating mood disorder pedigrees // Amer. J. Med. Genet., 2000. Vol. 96, N 4.-С.536
|
19.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
20.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
&uf('+1W2226#',v2226), ?>
|
|